← Back to patent-cliff list

CAS 1430074-33-1

N-[(2R)-2-[(4-Methoxyphenyl)methyl]-4-methylpent-4-en-1-yl]-4-methylbenzene-1-sulfonamide

Source drugs (routes using this intermediate)

DrugTierExpiry
Eptazocine hydrobromideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Eptazocine hydrobromideOptimised routesteps: 7total yield: /
(4R)-4-Benzyl-3-[3-(4-methoxyphenyl)propanoyl]-1,3-oxazolidin-2-one→Methylallyl iodide→(2R)-2-[(4-Methoxyphenyl)methyl]-4-methylpent-4-en-1-ol→1-[(2R)-2-(Azidomethyl)-4-methylpent-4-en-1-yl]-4-methoxybenzene→N-[(2R)-2-[(4-Methoxyphenyl)methyl]-4-methylpent-4-en-1-yl]-4-methylbenzene-1-sulfonamide→Formalin→(1S,6R)-10-Methoxy-1-methyl-4-(4-methylbenzene-1-sulfonyl)-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonine→(1S,6R)-10-Methoxy-1-methyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonine→(1S,6R)-1,4-Dimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonin-10-ol→(1S,6R)-10-Methoxy-1,4-dimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.